Location History:
- Pearland, TX (US) (2017)
- Houston, TX (US) (2022)
Company Filing History:
Years Active: 2017-2022
Title: Robia G Pautler: Innovator in Nanotechnology and Medical Applications
Introduction
Robia G Pautler is a distinguished inventor known for her contributions to the fields of nanotechnology and medical imaging. Based in Pearland, Texas, she has developed innovative solutions that enhance medical diagnostics and treatment methodologies. With a total of two patents to her name, Pautler's work is at the forefront of scientific advancement.
Latest Patents
Pautler's latest patents include a multifunctional fluorescent and MRI-active nanostructure. This invention serves as a Magnetic Resonance Imaging (MRI) enhancement agent, comprising a metal core, a dielectric shell containing at least one MRI contrast agent, and a metal shell encapsulating the dielectric shell. Additionally, she has developed methods utilizing carbon nanomaterials with antioxidant properties to treat oxidative stress. This therapeutic composition can include various forms of carbon nanomaterials, such as single-walled and multi-walled nanotubes, and is designed to provide significant antioxidant activity.
Career Highlights
Throughout her career, Pautler has worked with prestigious institutions, including William Marsh Rice University and Baylor College of Medicine. Her research has significantly impacted the understanding and application of nanotechnology in medicine, particularly in enhancing imaging techniques and developing therapeutic agents.
Collaborations
Pautler has collaborated with notable scientists, including James Mitchell Tour and Jacob Berlin. These partnerships have furthered her research and contributed to the advancement of her innovative projects.
Conclusion
Robia G Pautler's work exemplifies the intersection of technology and medicine, showcasing her commitment to improving healthcare through innovation. Her patents reflect a deep understanding of nanotechnology and its potential applications in medical science.